Literature DB >> 16195297

System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.

E Sevene1, S Lewin, A Mariano, G Woelk, A D Oxman, S Matinhure, J Cliff, B Fernandes, K Daniels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16195297      PMCID： PMC1239984          DOI： 10.1136/bmj.331.7519.765

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

2.  Magnesium for preventing and treating eclampsia: time for international action.

Authors:  Shirish S Sheth; Iain Chalmers
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

3.  Paying for pharmaceutical registration in developing countries.

Authors:  Warren A Kaplan; Richard Laing
Journal:  Health Policy Plan       Date:  2003-09       Impact factor: 3.344

Review 4.  Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean.

Authors:  L Duley
Journal:  Br J Obstet Gynaecol       Date:  1992-07

Review 5.  The European and developing countries clinical trails partnership.

Authors:  Piero Olliaro; Peter G Smith
Journal:  J HIV Ther       Date:  2004-09

6.  Malaria-related maternal mortality in urban Mozambique.

Authors:  A C Granja; F Machungo; A Gomes; S Bergström; B Brabin
Journal:  Ann Trop Med Parasitol       Date:  1998-04

7.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.

Authors: 
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

8.  Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

Authors:  Douglas Altman; Guillermo Carroli; Lelia Duley; Barbara Farrell; Jack Moodley; James Neilson; David Smith
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

Review 9.  Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

Authors:  L Duley; A M Gülmezoglu; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.

Authors:  Morten Aaserud; Simon Lewin; Simon Innvaer; Elizabeth J Paulsen; Astrid T Dahlgren; Mari Trommald; Lelia Duley; Merrick Zwarenstein; Andrew D Oxman
Journal:  BMC Health Serv Res       Date:  2005-11-01       Impact factor: 2.655
  10 in total
  25 in total

1.  Addressing inequalities in research capacity in Africa.

Authors:  Jimmy Volmink; Lola Dare
Journal:  BMJ       Date:  2005-10-01

Review 2.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

3.  Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be.

Authors:  Pisake Lumbiganon; A Metin Gülmezoglu; Gilda Piaggio; Ana Langer; Jeremy Grimshaw
Journal:  Bull World Health Organ       Date:  2007-10       Impact factor: 9.408

4.  Benefits of using magnesium sulphate (MgSO₄) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria.

Authors:  Ekechi Okereke; Babatunde Ahonsi; Jamilu Tukur; Salisu Mohammed Ishaku; Ayodeji Babatunde Oginni
Journal:  BMC Res Notes       Date:  2012-08-08

5.  Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.

Authors:  Bissallah A Ekele; Danjuma Muhammed; Lawal N Bello; Ibrahim M Namadina
Journal:  BMC Res Notes       Date:  2009-08-19

6.  Translating research into policy: lessons learned from eclampsia treatment and malaria control in three southern African countries.

Authors:  Godfrey Woelk; Karen Daniels; Julie Cliff; Simon Lewin; Esperança Sevene; Benedita Fernandes; Alda Mariano; Sheillah Matinhure; Andrew D Oxman; John N Lavis; Cecilia Stålsby Lundborg
Journal:  Health Res Policy Syst       Date:  2009-12-30

7.  Evidence-informed health policy 4 - case descriptions of organizations that support the use of research evidence.

Authors:  John N Lavis; Ray Moynihan; Andrew D Oxman; Elizabeth J Paulsen
Journal:  Implement Sci       Date:  2008-12-17       Impact factor: 7.327

8.  Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice.

Authors:  Maryam Bigdeli; Shamsa Zafar; Hafeez Assad; Adbul Ghaffar
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 9.  An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.

Authors:  Jeffrey Michael Smith; Richard F Lowe; Judith Fullerton; Sheena M Currie; Laura Harris; Erica Felker-Kantor
Journal:  BMC Pregnancy Childbirth       Date:  2013-02-05       Impact factor: 3.007

Review 10.  Why are women dying when they reach hospital on time? A systematic review of the 'third delay'.

Authors:  Hannah E Knight; Alice Self; Stephen H Kennedy
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.